{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T13:03:44Z","timestamp":1774616624969,"version":"3.50.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,3,28]],"date-time":"2023-03-28T00:00:00Z","timestamp":1679961600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,28]],"date-time":"2023-03-28T00:00:00Z","timestamp":1679961600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetol Metab Syndr"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Human Immuno-deficiency Virus (HIV) infection and antiretroviral therapy (ART) can cause metabolic disorders such as lipodystrophy, dyslipidemia, and insulin resistance, all of which are symptoms of metabolic syndrome (MetS). In Ethiopia, despite the existence of the primary studies, there was no pooled study conducted to summarize the country-level MetS among people living with HIV (PLHIV). Therefore, this study aims to estimate the pooled prevalence of MetS among PLHIV in Ethiopia.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A systematic search was conducted to retrieve studies on the prevalence of MetS among PLHIV in Ethiopia from PubMed, Google Scholar, Science Direct, Web of Sciences, HINARI, and other relevant sources. A random-effects model was used to estimate the MetS in this study. The overall variation between studies was checked by the heterogeneity test (I<jats:sup>2<\/jats:sup>). The Joanna Briggs Institute (JBI) quality appraisal criteria were used to assess the quality of the studies. The summary estimates were presented with forest plots and tables. Publication bias was checked with the funnel plot and Egger\u2019s regression test.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Overall, 366 articles were identified and evaluated using the PRISMA guidelines, with 10 studies meeting the inclusion criteria included in the final analysis. The pooled prevalence of MetS among PLHIV in Ethiopia was 21.7% (95% CI:19.36\u201324.04) using National Cholesterol Education Program Adult Treatment Panel III (NCEP\/ATP III) and 29.91% (95% CI: 21.54\u201338.28) using International Diabetes Federation (IDF) criteria. The lowest and highest prevalence of MetS were 19.14% (95%CI: 15.63\u201322.64) and 25.6% (95%CI: 20.18\u201331.08) at Southern Nation and Nationality People Region (SNNPR) and Addis Ababa, respectively. There was no statistical evidence of publication bias in both NCEP-ATP III and IDF pooled estimates.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>MetS was common among PLHIV in Ethiopia. Therefore, optimizing regular screening for MetS components and promoting a healthy lifestyle is suggested for PLHIV. Furthermore, more study is contributory to identify the barriers to implementing planned interventions and meeting recommended treatment goals. <jats:bold>Trial registration: <\/jats:bold>The review protocol was registered in the International Prospective Register of Systematic Reviews (PROSPERO): CRD42023403786.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13098-023-01034-9","type":"journal-article","created":{"date-parts":[[2023,3,28]],"date-time":"2023-03-28T08:07:22Z","timestamp":1679990842000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Metabolic syndrome among people living with HIV in Ethiopia: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4905-1189","authenticated-orcid":false,"given":"Derara","family":"Girma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5110-4075","authenticated-orcid":false,"given":"Hiwot","family":"Dejene","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7099-0420","authenticated-orcid":false,"given":"Leta Adugna","family":"Geleta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erean Shigign","family":"Malka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengistu","family":"Tesema","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mukemil","family":"Awol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Befekadu Tesfaye","family":"Oyato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,3,28]]},"reference":[{"key":"1034_CR1","unstructured":"WHO. HIV 2022 [14 February 2023]. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hiv-aids."},{"key":"1034_CR2","unstructured":"IN DANGER. : UNAIDS Global AIDS Update 2022. geneva: Joint United Nations Programme on HIV\/AIDS;, 2022."},{"issue":"9635","key":"1034_CR3","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/S0140-6736(08)61113-7","volume":"372","author":"Antiretroviral Therapy Cohort C","year":"2008","unstructured":"Antiretroviral Therapy Cohort C. Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies. Lancet. 2008;372(9635):293\u20139.","journal-title":"Lancet"},{"key":"1034_CR4","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.ijcard.2015.07.052","volume":"199","author":"C Nduka","year":"2015","unstructured":"Nduka C, Sarki A, Uthman O, Stranges S. Impact of antiretroviral therapy on serum lipoprotein levels and dyslipidemias: a systematic review and meta-analysis. Int J Cardiol. 2015;199:307\u201318.","journal-title":"Int J Cardiol"},{"issue":"3","key":"1034_CR5","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.4103\/jfmpc.jfmpc_1208_19","volume":"9","author":"DS Meena","year":"2020","unstructured":"Meena DS, Rai M, Singh SK, Tapadar J, Kumar D. Metabolic changes in the patients on second-line highly active antiretroviral therapy (HAART): a prospective cohort study from north India. J family Med Prim care. 2020;9(3):1550\u20134.","journal-title":"J family Med Prim care"},{"issue":"2","key":"1034_CR6","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s11904-022-00600-6","volume":"19","author":"CE Diggins","year":"2022","unstructured":"Diggins CE, Russo SC, Lo J. Metabolic consequences of antiretroviral therapy. Curr HIV\/AIDS Rep. 2022;19(2):141\u201353.","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"20","key":"1034_CR7","doi-asserted-by":"publisher","first-page":"3066","DOI":"10.1161\/CIRCULATIONAHA.105.539528","volume":"112","author":"PW Wilson","year":"2005","unstructured":"Wilson PW, D\u2019Agostino RB, Parise H, Sullivan L, Meigs JB. Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation. 2005;112(20):3066\u201372.","journal-title":"Circulation"},{"issue":"9","key":"1034_CR8","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1016\/j.jacc.2015.06.1328","volume":"66","author":"LS Sperling","year":"2015","unstructured":"Sperling LS, Mechanick JI, Neeland IJ, Herrick CJ, Despres JP, Ndumele CE, et al. The CardioMetabolic Health Alliance: Working toward a New Care Model for the metabolic syndrome. J Am Coll Cardiol. 2015;66(9):1050\u201367.","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"1034_CR9","doi-asserted-by":"publisher","first-page":"e0252320","DOI":"10.1371\/journal.pone.0252320","volume":"16","author":"LW Ang","year":"2021","unstructured":"Ang LW, Ng OT, Boudville IC, Leo YS, Wong CS. An observational study of the prevalence of metabolic syndrome in treatment-experienced people living with HIV in Singapore. PLoS ONE. 2021;16(6):e0252320.","journal-title":"PLoS ONE"},{"issue":"3","key":"1034_CR10","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1111\/hiv.13211","volume":"23","author":"WM Han","year":"2022","unstructured":"Han WM, Law MG, Choi JY, Ditangco R, Kumarasamy N, Chaiwarith R, et al. Weight changes, metabolic syndrome and all-cause mortality among asian adults living with HIV. HIV Med. 2022;23(3):274\u201386.","journal-title":"HIV Med"},{"key":"1034_CR11","doi-asserted-by":"crossref","unstructured":"Lu WL, Lee YT, Sheu GT. Metabolic Syndrome Prevalence and Cardiovascular Risk Assessment in HIV-Positive Men with and without Antiretroviral Therapy.Medicina. 2021;57(6).","DOI":"10.3390\/medicina57060578"},{"issue":"3","key":"1034_CR12","doi-asserted-by":"publisher","first-page":"e0150970","DOI":"10.1371\/journal.pone.0150970","volume":"11","author":"KA Nguyen","year":"2016","unstructured":"Nguyen KA, Peer N, Mills EJ, Kengne AP. A Meta-analysis of the metabolic syndrome prevalence in the Global HIV-Infected Population. PLoS ONE. 2016;11(3):e0150970.","journal-title":"PLoS ONE"},{"issue":"1","key":"1034_CR13","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13643-018-0927-y","volume":"8","author":"OO Todowede","year":"2019","unstructured":"Todowede OO, Mianda SZ, Sartorius B. Prevalence of metabolic syndrome among HIV-positive and HIV-negative populations in sub-saharan Africa-a systematic review and meta-analysis. Syst reviews. 2019;8(1):4.","journal-title":"Syst reviews"},{"issue":"1","key":"1034_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13690-020-00420-3","volume":"78","author":"GT Bune","year":"2020","unstructured":"Bune GT, Yalew AW, Kumie A. The extents of metabolic syndrome among antiretroviral therapy exposed and ART na\u00efve adult HIV patients in the Gedeo-zone, Southern-Ethiopia: a comparative cross-sectional study. Archives of Public Health. 2020;78(1):1\u201310.","journal-title":"Archives of Public Health"},{"issue":"5","key":"1034_CR15","doi-asserted-by":"publisher","first-page":"2833","DOI":"10.1016\/j.dsx.2019.07.051","volume":"13","author":"GT Bune","year":"2019","unstructured":"Bune GT, Yalew AW, Kumie A. The global magnitude of metabolic syndrome among antiretroviral therapy (ART) exposed and ART-naive adult HIV-infected patients in gedio-zone, southern Ethiopia: comparative cross-sectional study, using the adult treatment panel III criteria. Diabetes Metab Syndr. 2019;13(5):2833\u201341.","journal-title":"Diabetes Metab Syndr"},{"issue":"1","key":"1034_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13104-016-1953-2","volume":"9","author":"AT Hirigo","year":"2016","unstructured":"Hirigo AT, Tesfaye DY. Influences of gender in metabolic syndrome and its components among people living with HIV virus using antiretroviral treatment in Hawassa, southern Ethiopia. BMC Res Notes. 2016;9(1):1\u20137.","journal-title":"BMC Res Notes"},{"issue":"2","key":"1034_CR17","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.dsx.2014.04.008","volume":"8","author":"DY Tesfaye","year":"2014","unstructured":"Tesfaye DY, Kinde S, Medhin G, Megerssa YC, Tadewos A, Tadesse E, et al. Burden of metabolic syndrome among HIV-infected patients in Southern Ethiopia. Diabetes Metab Syndr. 2014;8(2):102\u20137.","journal-title":"Diabetes Metab Syndr"},{"key":"1034_CR18","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s13098-018-0312-y","volume":"10","author":"DD Bosho","year":"2018","unstructured":"Bosho DD, Dube L, Mega TA, Adare DA, Tesfaye MG, Eshetie TC. Prevalence and predictors of metabolic syndrome among people living with human immunodeficiency virus (PLWHIV). Diabetol Metab Syndr. 2018;10:10.","journal-title":"Diabetol Metab Syndr"},{"key":"1034_CR19","first-page":"43","volume":"13","author":"T Berhane","year":"2012","unstructured":"Berhane T, Yami A, Alemseged F, Yemane T, Hamza L, Kassim M, et al. Prevalence of lipodystrophy and metabolic syndrome among HIV positive individuals on highly active anti-retroviral treatment in Jimma, South West Ethiopia. Pan Afr Med J. 2012;13:43.","journal-title":"Pan Afr Med J"},{"key":"1034_CR20","first-page":"117955142210780","volume":"15","author":"M Woldu","year":"2022","unstructured":"Woldu M, Minzi O, Shibeshi W, Shewaamare A, Engidawork E. Biomarkers and prevalence of Cardiometabolic Syndrome among People living with HIV\/AIDS, Addis Ababa, Ethiopia: A Hospital-Based study. Clin Med Insights: Endocrinol Diabetes. 2022;15:11795514221078029.","journal-title":"Clin Med Insights: Endocrinol Diabetes"},{"key":"1034_CR21","first-page":"297","volume":"14","author":"E Woldeyes","year":"2022","unstructured":"Woldeyes E, Fisseha H, Mulatu HA, Ephrem A, Benti H, Alem MW, et al. Prevalence of Clinical Cardiovascular Disease Risk factors among HIV infected patients on anti-retroviral treatment in a Tertiary Hospital in Ethiopia. HIV AIDS (Auckl). 2022;14:297\u2013309.","journal-title":"HIV AIDS (Auckl)"},{"issue":"5","key":"1034_CR22","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1016\/j.dsx.2020.08.002","volume":"14","author":"A Gebrie","year":"2020","unstructured":"Gebrie A. The burden of metabolic syndrome in patients living with HIV\/AIDS receiving care at referral hospitals of Northwest Ethiopia: a hospital-based cross-sectional study, 2019. Diabetes Metab Syndr. 2020;14(5):1551\u20136.","journal-title":"Diabetes Metab Syndr"},{"issue":"1","key":"1034_CR23","first-page":"13","volume":"4","author":"Z Ataro","year":"2020","unstructured":"Ataro Z, Ashenafi W. Metabolic syndrome and associated factors among adult HIV positive people on antiretroviral therapy in Jugal hospital, Harar, Eastern Ethiopia. East Afr J Health Biomedical Sci. 2020;4(1):13\u201324.","journal-title":"East Afr J Health Biomedical Sci"},{"key":"1034_CR24","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.","journal-title":"BMJ"},{"issue":"5","key":"1034_CR25","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1111\/j.1464-5491.2006.01858.x","volume":"23","author":"KG Alberti","year":"2006","unstructured":"Alberti KG, Zimmet P, Shaw J. Metabolic syndrome\u2013a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet medicine: J Br Diabet Association. 2006;23(5):469\u201380.","journal-title":"Diabet medicine: J Br Diabet Association"},{"key":"1034_CR26","volume-title":"Systematic reviews of etiology and risk","author":"SMZ Moola","year":"2017","unstructured":"Moola SMZ, Tufanaru C, Aromataris E, Sears K, Sfetcu R, Currie M, Qureshi R, Mattis P, Lisy K, Mu P-F. In: Aromataris EMZ, editor. Systematic reviews of etiology and risk. Joanna Briggs Institute Reviewer\u2019s Manual: The Joanna Briggs Institute; 2017."},{"issue":"7414","key":"1034_CR27","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JP Higgins","year":"2003","unstructured":"Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557\u201360.","journal-title":"BMJ"},{"issue":"4","key":"1034_CR28","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.2307\/2533446","volume":"50","author":"CB Begg","year":"1994","unstructured":"Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50(4):1088\u2013101.","journal-title":"Biometrics"},{"issue":"2","key":"1034_CR29","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1007\/s40200-020-00552-x","volume":"19","author":"M Woldu","year":"2020","unstructured":"Woldu M, Minzi O, Engidawork E. Prevalence of cardiometabolic syndrome in HIV-infected persons: a systematic review. J Diabetes Metab Disord. 2020;19(2):1671\u201383.","journal-title":"J Diabetes Metab Disord"},{"issue":"1","key":"1034_CR30","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1007\/s40200-021-00815-1","volume":"20","author":"T Jemere","year":"2021","unstructured":"Jemere T, Kefale B. Metabolic syndrome and its associated factors in Ethiopia: a systematic review and meta-analysis. J Diabetes Metab Disord. 2021;20(1):1021\u201331.","journal-title":"J Diabetes Metab Disord"},{"key":"1034_CR31","doi-asserted-by":"publisher","first-page":"2701309","DOI":"10.1155\/2020\/2701309","volume":"2020","author":"S Ambachew","year":"2020","unstructured":"Ambachew S, Endalamaw A, Worede A, Tegegne Y, Melku M, Biadgo B. The prevalence of metabolic syndrome in Ethiopian Population: a systematic review and Meta-analysis. J Obes. 2020;2020:2701309.","journal-title":"J Obes"},{"issue":"27","key":"1034_CR32","doi-asserted-by":"publisher","first-page":"e20845","DOI":"10.1097\/MD.0000000000020845","volume":"99","author":"SJ Masyuko","year":"2020","unstructured":"Masyuko SJ, Page ST, Kinuthia J, Osoti AO, Polyak SJ, Otieno FC, et al. Metabolic syndrome and 10-year cardiovascular risk among HIV-positive and HIV-negative adults: a cross-sectional study. Medicine. 2020;99(27):e20845.","journal-title":"Medicine"},{"issue":"3","key":"1034_CR33","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1080\/15284336.2017.1311502","volume":"18","author":"L Calza","year":"2017","unstructured":"Calza L, Colangeli V, Magistrelli E, Rossi N, Del Rosselli E, Bussini L, et al. Prevalence of metabolic syndrome in HIV-infected patients naive to antiretroviral therapy or receiving a first-line treatment. HIV Clin Trial. 2017;18(3):110\u20137.","journal-title":"HIV Clin Trial"},{"issue":"6","key":"1034_CR34","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1007\/s11906-016-0656-3","volume":"18","author":"R Martin-Iguacel","year":"2016","unstructured":"Martin-Iguacel R, Negredo E, Peck R, Friis-Moller N. Hypertension is a key feature of the metabolic syndrome in subjects aging with HIV. Curr Hypertens Rep. 2016;18(6):46.","journal-title":"Curr Hypertens Rep"},{"issue":"9","key":"1034_CR35","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1056\/NEJMoa1506816","volume":"373","author":"ISS Group","year":"2015","unstructured":"Group ISS, Lundgren JD, Babiker AG, Gordin F, Emery S, Grund B, et al. Initiation of antiretroviral therapy in early asymptomatic HIV infection. N Engl J Med. 2015;373(9):795\u2013807.","journal-title":"N Engl J Med"}],"container-title":["Diabetology &amp; Metabolic Syndrome"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13098-023-01034-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13098-023-01034-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13098-023-01034-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,28]],"date-time":"2023-03-28T08:15:34Z","timestamp":1679991334000},"score":1,"resource":{"primary":{"URL":"https:\/\/dmsjournal.biomedcentral.com\/articles\/10.1186\/s13098-023-01034-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,28]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1034"],"URL":"https:\/\/doi.org\/10.1186\/s13098-023-01034-9","relation":{},"ISSN":["1758-5996"],"issn-type":[{"value":"1758-5996","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,28]]},"assertion":[{"value":"3 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"61"}}